Last month the final two Oxford-GSK Institute of Molecular and Computational Medicine (IMCM) Fellows were welcomed to NDM\u2019s Centre for Human Genetics. Dr Martina Hallegger and Dr Charmaine Lang join Dr Steph Fowler to build capacity in neurodegenerative disease research at the Centre.
The $5000 Scholarship Award for 2024 \ufeffwas granted to Dr. Grace Hood for her One Health Project titled \r\n\"Deforestation as a driver of emerging viral spillover events at the human-animal-environment interface in Malaysian Borneo\"
A pioneering study published in Nature Immunology offers unprecedented insights into cellular responses to common treatments, paving the way to transform the treatment landscape for these chronic inflammatory conditions.
A new study published in Nature Communications has identified a new potential transmission route for H5 highly pathogenic avian influenza viruses (HPAI). Understanding actual \u201cbird flu\u201d rates in humans will help prevent further spillover and a potential new pandemic.
Magda Mareckova, a DPhil Student working with Prof Krina Zondervan, has created single-cell reference atlas of the human endometrium. The study was published in Nature Genetics.
A study, published by the New England Journal of Medicine, has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.
Scientists from the Centre for Human Genetics at Nuffield Department of Medicine are taking the initial steps in developing the UK\u2019s first vaccine to prevent cancer in people with Lynch syndrome, thanks to funding from Cancer Research UK.
The new recombinant shingles vaccine \u2018Shingrix\u2019 is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine.
A global collaboration led by scientists at the University of Oxford has discovered that genetic variants in a specific gene cause a rare neurodevelopmental disorder (NDD). NDD is a collective term for severe impairments in how the brain functions that impact learning, behaviour, speech, and movement. Most NDDs are thought to be genetic and caused by changes to DNA, however, to date, around 60% of individuals with these conditions do not know the specific DNA change that causes their disorder.
Globally kidney disease is forecast to be the 5th leading cause of death by 2040, and in the UK more than 3 million people are living with the most severe stages of chronic kidney disease. Chronic kidney disease is often due to autoimmune damage to the filtration units of the kidney, known as the glomeruli, which can occur in lupus, a disease which disproportionally affects women and people of non-white ethnicities, groups often underrepresented in research. Treatment options are limited, can have life threatening side-effects and often don\u2019t slow the disease, which can then progress to end stage, requiring dialysis or a kidney transplant.
![\"\"](\"https://www.chg.ox.ac.uk/news/three-new-oxford-gsk-imcm-fellows-welcomed-to-the-centre-for-human-genetics/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n